I just can't believe it! Seven out of 500 feeble elderly patients that failed first line treatment died during a study? What are the chances of 7 out of 500 healthy elderly persons dying in a year? Statistically pretty good, so you're basically trying to scare people with a falacious argument. I suspect you are either short and trying to frighten people to your own benefit, or you want to purchase more shares at a lower price. Either way you demonstrate the morality of a reptile.
Given their age and prognosis (months to live) and the overall results of sapacitabine, what would you do? I would think every candidate would accept the risk. Why wouldn't they? This seems too logical. Why do you guys continue to harp on this issue?